Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Recent Developments in Graves’ Ophthalmopathy
source: Springer
year: N/A
authors: Mark F. Prummel
summary/abstract:Recent Developments in Graves’ ophthalmopathy offers an overview of the pathogenesis, assessment and management of patients with thyroid-associated eye disease. Each chapter is written by an expert and truly represents the current state of the art on the particular topic. This book can therefore almost be considered a textbook on this enigmatic disorder.
Recent developments in Graves’ ophthalmopathy is designed for all those interested in this disease, including basic scientists, clinical endocrinologists, ophthalmologists, radiotherapists, and orbital surgeons. The book gives a comprehensive overview of all aspects of Graves’ ophthalmopathy. Subjects covered include the pathology of Graves’ eye disease and the controversial views on its autoimmune pathogenesis; assessment of the eye changes using reliable measurements; medical management of Graves’ eye disease with an overview of the many treatment options available to the clinician, including orbital radiotherapy and other immunosuppressive treatments; management of the thyroid disease; and finally, the techniques for performing various surgical procedures, which are explained and illustrated.
read more
Related Content
-
Fatemeh Rajaii, MD, PhDFatemeh Rajaii is an Assistant Professor...
-
Teprotumumab Significantly Improves Proptosis in Thyroid eye DiseasePatients with thyroid eye disease treate...
-
Management of Endocrine Disease: Rituximab Therapy for Graves’ Orbitopathy – Lessons From Randomized Con...Rituximab (RTX) use in open-label series...
-
Robert C. Sergott, MDRobert C. Sergott is Chief of the neuro-...
-
Related Quality of Life Questionnaire Specific to Dysthyroid Ophthalmopathy Evaluated in a Population of Patients Wi...Objective: The aim of this study was to...
-
How patients experience thyroid eye diseaseObjective: To determine the impact of t...
-
Teprotumumab and the Evolving Therapeutic Landscape in Thyroid Eye DiseaseContext: Thyroid eye disease (TED) is a...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.